Skip to main content
Premium Trial:

Request an Annual Quote

No Word on How It Will Work for People Who Are Red-Green Colorblind

MIT's Technology Review reports on Katushka, a bright-red fluorescent protein that can be seen from deep within the bodies of small animals, making possible non-invasive, live-cell imaging of disease progression. Developed by researchers at Shemiakin-Ovchinnikov Institute of Bioorganic Chemistry in Moscow, the new protein belongs to the far-infrared spectrum, which will allow it to image tagged genes, cells, or tissues that require deep tissue penetration. Their research was published in Nature Methods.

The Scan

Could Cost Billions

NBC News reports that the new Alzheimer's disease drug from Biogen could cost Medicare in the US billions of dollars.

Not Quite Sent

The Biden Administration likely won't meet its goal of sending 80 million SARS-CoV-2 vaccine doses abroad by the end of the month, according to the Washington Post.

DTC Regulation Proposals

A new report calls on UK policymakers to review direct-to-consumer genetic testing regulations, the Independent reports.

PNAS Papers on Mosquito MicroRNAs, Acute Kidney Injury, Trichothiodystrophy

In PNAS this week: microRNAs involved in Aedes aegypti reproduction, proximal tubule cell response to kidney injury, and more.